Hugo Cordellat Martín

Hugo Cordellat Martín is a seasoned professional in the pharmaceutical industry with extensive experience in account management and sales. Currently serving as a Senior Key Account Manager in the Global Rare Business Unit at Alnylam Pharmaceuticals since April 2022, previous roles include National Key Account Manager for Rare Diseases at Takeda from September 2018 to November 2021, and Key Account Manager for Inflammatory Bowel Disease at Novartis from June 2017 to August 2018. Hugo's earlier career includes various sales and medical roles at The Janssen Pharmaceutical Companies of Johnson & Johnson, spanning from October 2008 to June 2017, and a position as a Human Resources Consultant at Martin Seattle Consultants from June 2005 to June 2008. Educational qualifications comprise a Licenciado en Investigación y técnicas de mercado from the University of Valencia, a Master's in HR Management from ESIC Business & Marketing School, and a Master's in Occupational Risk Prevention from Esine, all contributing to a robust foundation in psychology and organizational practices.